DuPont de Nemours, Inc. · NYSE:DD
DuPont de Nemours — DuPont — Q3 2015 Earnings Presentation
36 slides from DuPont de Nemours's earnings presentation, Oct 27, 2015
Slide 1: DuPont Third-Quarter 2015 Earnings Conference Call
DuPont Third-Quarter 2015 Earnings Conference Call October 27, 2015
Slide 2: Regulation G and Forward-Looking Statements
Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company. Th
Slide 3: 3Q and YTD 2015 Financial Results
3Q and YTD 2015 Financial Results $ in millions, except EPS 3Q15 vs. 3Q14 YTD15 vs. YTD14 EPS Operating earnings* $0.13 (67%) $2.49 (11%) Operating earnings, ex $0.30 (23%) $3.02 8% currency* GAAP earnings $0.14 (61%) $2.33 (16%) 3Q15 vs. 3Q14 YTD15 YTD14 Consolidated Net Sales $4,873 (17%) $19,831
Slide 4: 3Q 2015 Operating EPS Variance
3Q 2015 Operating EPS* Variance $0.06 ($0.02) ($0.08) ($0.22) $0.39 Currency Operating ($0.17) EPS* $0.13 Operating EPS* 3Q14 Corp Exp & Int EGL Tax Rate Segment Results 3Q15 Key Factors Lower corporate expense and interest contributed $0.06 per share to operating earnings on disciplined cost savi
Slide 5: Global Net Sales – Regional Highlights
Global Net Sales – Regional Highlights 3Q 2015 Net Sales by Region 3Q 2014 Net Sales by Region U.S. & Canada Latin America U.S. & Canada 29% 16% 32% Latin America 20% Developed Asia Developing EMEA 10% Developing EMEA 7% 8% Developed Asia 10% Developed EMEA Developing Asia Developed EMEA 18% 17% 17%
Slide 6: 3Q 2015 Segment Operating Earnings Variance
3Q 2015 Segment Operating Earnings* Variance ($ in millions) $14 $10 $3 ($38) ($39) ($49) ($154) $686 Segment Operating Earnings* $433 Segment Operating Earnings* 3Q14 E&C IB N&H Other S&P Perf Mat Ag 3Q15 Key Factors Electronics & Communications earnings up on cost reductions, continued productiv
Slide 7: Balance Sheet and Cash
Balance Sheet and Cash September 30, 2015 Free Cash Flow Free Cash Flow* • About even with prior year YTD 14 YTD 15 • Reflects expected seasonal working capital outflows 0.0 -1.0 $ Billions -2.0 Balance Sheet -3.0 • $6.2B net debt** -4.0 • $2 billion share repurchase launched • 29 million shares ret
Slide 8: Other Highlights
Other Highlights • Redesign initiative on track, contributed incremental $0.10 per share to operating earnings in the quarter; on track to deliver ~$0.40 per share in incremental savings for full year 2015, in addition to the $0.07 per share realized last year • Accelerated annual run rate cost savi
Slide 9: Full Year 2015 Expectations and Outlook
Full Year 2015 Expectations and Outlook • Net sales down about 11 - 12 percent versus prior year due to impact of currency, challenging agriculture environment and portfolio changes • Operating EPS* about $2.75 per share • Includes currency headwind of $0.72 per share • Base tax rate 22% • Unfavorab
Slide 10: Electronics & Communications
Electronics & Communications 3Q Sales Vol -7%, Local Price -5%, Currency -2%, Port./Other 0% 3Q Comments 650 • Sales – Down 14 percent as volume growth in Tedlar® film in photovoltaics and products used in consumer electronics 600 applications was more than offset by the impact of $ in Millions comp
Slide 11: Industrial Biosciences
Industrial Biosciences 3Q Sales 3Q Comments Vol 7%, Local Price -4%, Currency -6%, Port./Other 0% • Sales – Down 3 percent as 7 percent volume growth was more 350 than offset by the impact of currency and lower prices, primarily for biomaterials. 325 • Volume improved across the business, driven pri
Slide 12: Nutrition & Health
Nutrition & Health 3Q Sales Vol 0%, Local Price 0%, Currency-9%, Port./Other -1% 3Q Comments • Sales – 10 percent lower primarily due to a 9 percent negative 950 impact from currency • Strong growth in probiotics, ingredient systems and texturants 900 $ in Millions was offset by competitive challeng
Slide 13: Safety & Protection
Safety & Protection Protection Technologies (DPT), Building Innovations (BI), Sustainable Solutions (DSS) 3Q Comments 3Q Sales • Sales – Down 15 percent, driven by softness in volume, currency and portfolio changes Vol -6%, Local Price -1%, Currency-4%, Port./Other -4% • Increased demand for medical
Slide 14: Performance Materials
Performance Materials Performance Polymers (DPP), Packaging & Industrial Polymers (P&IP) 3Q Comments 3Q Sales • Sales – Down 15 percent on negative currency impact and lower ethylene prices and volume; Currency and portfolio reduced sales by 7 Vol -3%, Local Price -5%, Currency -6%, Port./Other -1%
Slide 15: Agriculture
Agriculture Pioneer, Crop Protection 3Q Sales 3Q Comments • Demand for seed and crop protection products, primarily in Brazil, further Vol -17%, Local Price 3%, Currency -15%, Port./Other -1% weakened in the quarter impacted by macroeconomic and competitive pressures 1600 • Sales – 30 percent lower
Slide 16: Appendix 1: Third Quarter 2015 Segment Commentary
APPENDIX 1: THIRD QUARTER 2015 SEGMENT COMMENTARY This data should be read in conjunction with the Company’s third quarter earnings news release dated October 27, 2015, DuPont’s 3Q 2015 Earnings Conference Call presentation materials and reconciliations of non-GAAP to GAAP measures included in the p
Slide 17: Segment Commentary: Electronics & Communications
Segment Commentary Third Quarter Earnings 2015 Electronics & Communications In Electronics & Communications, operating earnings improved $14 million to $104 million, or 16 percent as cost reductions and continued productivity more than offset lower sales. Sales were 14 percent lower as volume growth
Slide 18: Segment Commentary: Industrial Biosciences
Segment Commentary Third Quarter Earnings 2015 Industrial Biosciences In Industrial Biosciences, sales declined 3 percent as volume gains across the business were more than offset by the impact of currency and lower prices. Volume growth in enzymes was driven by solid demand in food (primarily U.S.
Slide 19: Segment Commentary: Nutrition & Health
Segment Commentary Third Quarter Earnings 2015 Nutrition & Health In Nutrition & Health, the business again delivered solid results and margin improvement despite significant headwinds from currency. Operating earnings increased $3 million as cost reductions and continued productivity more than offs
Slide 20: Segment Commentary: Safety & Protection
Segment Commentary Third Quarter Earnings 2015 Safety & Protection Sales of $831 million declined 15 percent on a 4-percent negative impact of currency and a 4-percent negative impact from the Sontara® divestiture. Increased demand for Tyvek® protective material, including medical packaging, was mor
Slide 21: Segment Commentary: Performance Materials
Segment Commentary Third Quarter Earnings 2015 Performance Materials Sales of $1.3 billion were down 15 percent on the negative impact of currency, lower ethylene prices and volumes, and the impact of the prior year sale of a majority interest in a joint venture. Price was down 5 percent in the quar
Slide 22: Segment Commentary: Agriculture
Segment Commentary Third Quarter Earnings 2015 Agriculture In Agriculture, near term conditions remain challenging. Demand for seed and crop protection products, primarily in Brazil, further weakened in the quarter impacted by macroeconomic and competitive pressures. In Brazil, where the planting se
Slide 23: Segment Commentary: Agriculture (continued)
Segment Commentary Third Quarter Earnings 2015 Agriculture (continued) Turning to the outlook, the fourth quarter in Agriculture is driven by the completion of the Brazil summer season and shipments to position product for the upcoming Safrinha season in Brazil and for the 2016 Northern hemisphere s
Slide 24: Quarterly Supplemental Financial Data and Non-GAAP Reconciliations
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES QUARTERLY SUPPLEMENTAL FINANCIAL DATA AND NON-GAAP RECONCILIATIONS (UNAUDITED) SEPTEMBER 30, 2015 INDEX PAGE SELECTED OPERATING RESULTS 24 SELECTED INCOME STATEMENT DATA 25 SEGMENT NET SALES 26 SEGMENT PRETAX OPERATING INCOME 27 SEGM
Slide 25: Selected Operating Results
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SELECTED OPERATING RESULTS (UNAUDITED) (dollars in millions) Year Year Year Year Year 2015 3Q15 2Q15 1Q15 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 2011 INCOME STATEMENT DATA Consolidated Net Sales 19,831 4,873 7,121 7,8
Slide 26: Selected Income Statement Data – Operating Earnings
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SELECTED INCOME STATEMENT DATA OPERATING EARNINGS (UNAUDITED) (dollars in millions, except per share) Year Year Year Year Year 2015 3Q15 2Q15 1Q15 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 2011 Consolidated Net Sales 19,
Slide 27: Segment Net Sales
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SEGMENT NET SALES (UNAUDITED) (dollars in millions) SEGMENT NET SALES Year Year Year Year Year 2015 3Q15 2Q15 1Q15 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 2011 Agriculture 8,248 1,093 3,218 3,937 11,296 1,732 1,563 3,6
Slide 28: Income from Continuing Operations – Segment Pretax Operating Income
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES INCOME FROM CONTINUING OPERATIONS (UNAUDITED) (dollars in millions) SEGMENT PRETAX OPERATING INCOME (LOSS) Year Year Year Year Year 2015 3Q15 2Q15 1Q15 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 2011 Agriculture 1,878 (63
Slide 29: Segment Operating Earnings
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES OPERATING EARNINGS (UNAUDITED) (dollars in millions) SEGMENT OPERATING EARNINGS Year Year Year Year Year 2015 3Q15 2Q15 1Q15 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 2011 Agriculture 1,700 (210) 772 1,138 2,352 134 (56)
Slide 30: Significant Items by Segment – Pretax Operating Income
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SIGNIFICANT ITEMS BY SEGMENT - PRETAX OPERATING INCOME (UNAUDITED) (dollars in millions) SEGMENT PRETAX IMPACT OF Year Year Year Year Year SIGNIFICANT ITEMS 2015 3Q15 2Q15 1Q15 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 2
Slide 31: Reconciliation of Non-GAAP Measures
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions, except per share) Year Year Year Year Year 2015 3Q15 2Q15 1Q15 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 2011 RECONCILIATION OF DILUTED EPS (1) Operat
Slide 32: Reconciliation of Non-GAAP Measures – Net Debt
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions) Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Dec-11 CALCULATION OF NET DEBT Cash and Cash Equivalents 3,324 4,746 3,622 6,91
Slide 33: Reconciliation of Non-GAAP Measures – Segment Margin
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) Year Year Year Year Year 2015 3Q15 2Q15 1Q15 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 2011 SEGMENT PTOI MARGIN % (PTOI / Segment Net Sales) (1) Agriculture 22.8% -5.8% 23.
Slide 34: Operating Earnings Excluding Impact of Currency
OPERATING EARNINGS EXCLUDING IMPACT OF CURRENCY (UNAUDITED) (dollars in millions) Reconciliation of Segment Operating Earnings excluding the impact of currency (Non-GAAP) Segment operating earnings excluding the impact of currency assumes current operating earnings results using foreign currency exc
Slide 35: Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF BASE INCOME TAX RATE TO EFFECTIVE INCOME TAX RATE (UNAUDITED) Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items and non-operating pension/
Slide 36: Copyright and trademark notice
Copyright©©2014 Copyright 2015DuPont DuPontororitsits affiliates. affiliates. All All rights rights reserved. reserved. The DuPont DuPontOvalOvalLogo, Logo,DuPont™, DuPont™, The Themiracles miracles of science™ of science™ and all and all products products, unlessdenoted otherwise with indicated, ™